Adastra Holdings Ltd · CSE:XTRX
Adastra — Investor Presentation (April 2023)
16 slides from Adastra's investor presentation, April 2023
Slide 1: Investor Presentation: Cannabis Through Art and Science
INVESTOR PRESENTATION CANNABIS THROUGH ART AND SCIENCE April 2023 1
Slide 2: The Art, The Science, The Expertise
THE ART THE SCIENCE Adastra has become one of Canada’s leaders in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. It serves medical markets and engages in forward-looking therapeutic applications. With cannabis concentrate products sold through retailers at
Slide 3: Investment Highlights
INVESTMENT HIGHLIGHTS STRATEGIC PURSUIT OF LICENSING AND AMENDMENTS Leading producer of cannabis products and in-house sought-after brands distributed for the adult-use and medical markets. Adastra is recognized as a high-capacity processor and co-manufacturer, supplying many top selling brands thro
Slide 4: Key Product Offerings
KEY PRODUCT OFFERINGS SUPER/SUB CRYO ETHANOL HYDROCARBON FULL SPECTRUM DRIED FLOWER CRITICAL CO2 Full-Spectrum Vape, Distillate Vape Live Resin, Shatter, Shatter, Live Extract Pre-Rolls, Infused Pre- Cartridges, Terp Sauce Cartridges, Tinctures THCa Diamonds, Full Cartridges and Rolls, Large format
Slide 5: Experienced Leadership Team
EXPERIENCED LEADERSHIP TEAM With a background firmly rooted in Smoke is a highly accomplished CEO, entrepreneur, leader, medicine, cannabis production and board member and philanthropist with leadership across the entrepreneurship, Michael has founded five consumer products, beverage, cannabis, hosp
Slide 6: A Platform for Accelerated Growth in Canada
A PLATFORM FOR ACCELERATED GROWTH IN CANADA Trusted global leader in pharma-quality, development and manufacturing of cannabis API, and derivative products. EXTRACT SCIENCE Our extraction methodologies and industry-leading Cannabis processing, innovative product development and equipment are designe
Slide 7: Extraction
EXTRACTION Adastra Labs is a Health Canada licensed Standard Processor, cannabis product formulator and co-manufacturer. Our 13,500 sq. ft facility is located in Langley, BC, Canada. In 2021, Adastra received its sales license to sell products directly to provincial distributors. Distillate & Full T
Slide 8: Adastra Analytics
ADASTRA ANALYTICS IN-HOUSE TESTING LAB Licensed by Health Canada in 2019, Adastra Analytics is Adastra Labs' co-located analytical testing lab. Adastra conducts in-process cannabinoid potency testing, enhancing process efficiency and product quality assurance. It also offers QA/ QC and compliance se
Slide 9: Owns 100% of Two Top-Performing Canadian Concentrates Brands
OWNS 100% OF TWO TOP-PERFORMING CANADIAN CONCENTRATES BRANDS AWARD-WINNING EXTRACTS Proudly Canadian and fiercely passionate about cannabis concentrates, Phyto Extractions is a legacy purveyor of award-winning extracts. Evolving from our legacy roots, we carefully consider hardware, formulation ingr
Slide 10: One of British Columbia's Leading Medical Cannabis Clinics
ONE OF BRITISH COLUMBIA’S LEADING MEDICAL CANNABIS AND FORWARD-THINKING THERAPY CLINICS PerceiveMD is a multidisciplinary team-based, patient-focused centre providing free, comprehensive assessments for medical cannabis. SEPT 2021: PURCHASED 100% OF PERCEIVE MD (1) PerceiveMD positions Adastra for e
Slide 11: Growing Product Portfolio and Availability
GROWING PRODUCT PORTFOLIO AND AVAILABILITY EXPANDING DISTRIBUTION WITH GROWTH DRIVERS PROVINCIAL WHOLESALERS • Introduction of new products, into desired categories • Retail & market penetration • 1,600 Canadian retailers' stock Adastra • New channels distribution regions • Maritime provinces • Opti
Slide 12: Building Momentum
BUILDING MOMENTUM • Gross revenues of $3.0SM in Q2 2022, compared to $1.24M in Q2 2021, representing an increase of 146%, demonstrating significant demand for in-house cannabis Q2 2022 concentrate brands and products. • Launched Endgame Extracts brand, met with high demand and 100% sell through in h
Slide 13: YTD 2022 Financial Metrics
YTD 2022 FINANCIAL METRICS Note: For the 9 months ended September 30, 2022 compared to the same period, in the previous year. $9.14M 151% $3.56M 38.9% Revenue Y/Y Growth Gross Profit Gross Margin 13
Slide 14: Capital Structure
CAPITAL STRUCTURE CSE: XTRX TICKER Shares Outstanding Total Shares (as of April 12, 2023) $1.33 SHARE PRICE (1) Common Shares 55,970,547 Options 3,665,000 $0.11-$2.00 52 WEEK RANGE Warrants 122,727 Total Shares Outstanding (Fully Diluted) 59,758,274 $74.44M MARKET CAP Reserve for issuance 3,787,
Slide 15: Disclaimer
DISCLAIMER Investors and prospective investors should rely only on the information contained in the disclosure filings (the "Filings") o f Adastra Holdings Ltd. (the "Company"). This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information cont
Slide 16: Get In Touch With Us
Get In Touch With Us MICHAEL FORBES, CEO & DIRECTOR michael@adastraholdings.ca +1 (250) 882-3784 16
Adastra Holdings — Investor Presentation (April 2023) on 6ix